Animal models of cisplatin-induced neuropathic pain

被引：0

作者：

Li, Ningxin ^{[1
]}

Li, Mingzhu ^{[2
]}

Jin, Shengbo ^{[3
]}

Yu, Jun ^{[3
]}

Wei, Hongzhe ^{[1
]}

Wang, Wenping ^{[2
]}

Ma, Siyao ^{[2
]}

Jiang, Yuxin ^{[3
]}

Liu, Qian ^{[3
]}

Yao, Huini ^{[1
]}

机构：

[1] China Med Univ, Shenyang, Peoples R China

[2] China Med Univ, Canc Hosp, Liaoning Canc Hosp & Inst, Shenyang, Peoples R China

[3] Liaoning Univ Tradit Chinese Med, Shenyang, Peoples R China

来源：

ANIMAL MODELS AND EXPERIMENTAL MEDICINE | 2025年

基金：

中国国家自然科学基金;

关键词：

animal models; chemotherapy; cisplatin; peripheral neuropathic pain; INDUCED PERIPHERAL NEUROPATHY; MECHANICAL ALLODYNIA; GABAPENTIN;

D O I：

10.1002/ame2.12548

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Cisplatin chemotherapy has been used as the main treatment for different types of cancer. However, cisplatin chemotherapy-induced peripheral neuropathic pain (CIPNP) seriously affects the treatment process and quality of life of patients. In addition, it impacts the underlying mechanism and prevention and treatment strategies, indicating that drug selection and efficacy evaluation need to be further investigated. Furthermore, an animal model that is more consistent with the pathological mechanism needs to be developed. In this study, we describe and discuss the methods of developing and detecting CIPNP models in rats and mice induced by cisplatin chemotherapy. The aim was to improve the modeling rate and develop animal models that are more consistent with the developmental pattern of the disease. In addition, the study provides ideal reference animal models for clinical research and drug discovery and development.

引用

页数：9

共 50 条

[31] Corydalis saxicola Alkaloids Attenuate Cisplatin-Induced Neuropathic Pain by Reducing Loss of IENF and Blocking TRPV1 Activation
Kuai, Cui-Ping
Ju, Lin-Jie
Hu, Pei-Pei
Huang, Fang
AMERICAN JOURNAL OF CHINESE MEDICINE, 2020, 48 (02): : 407 - 428
[32] Peripheral and central changes induced by neural mobilization in animal models of neuropathic pain: a systematic review
Salniccia, Federico
de Vidania, Silvia
Martinez-Caro, Leticia
FRONTIERS IN NEUROLOGY, 2024, 14
[33] Antiepileptics and the treatment of neuropathic pain: Evidence from animal models
Blackburn-Munro, G
Erichsen, HK
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (23) : 2961 - 2976
[34] Role of Exercise on Inflammation Cytokines of Neuropathic Pain in Animal Models
Zheng, Ya-Nan
Zheng, Yi-Li
Wang, Xue-Qiang
Chen, Pei-Jie
MOLECULAR NEUROBIOLOGY, 2024, 61 (12) : 10288 - 10301
[35] Predictive validity of pharmacologic interventions in animal models of neuropathic pain
Honore, Per Hartvig
Basnet, Anna
Kristensen, Pernille
Andersen, Lene Munkholm
Neustrup, Signe
Mollgaard, Pia
Eljaja, Laila
Bjerrum, Ole J.
SCANDINAVIAN JOURNAL OF PAIN, 2011, 2 (04) : 178 - 184
[36] Sympathetic component of neuropathic pain: Animal models and clinical diagnosis
Urban, LA
BEHAVIORAL AND BRAIN SCIENCES, 1997, 20 (03) : 468 - +
[37] Neuropathic Pain in Animal Models of Nervous System Autoimmune Diseases
Tian, David H.
Perera, Chamini J.
Moalem-Taylor, Gila
MEDIATORS OF INFLAMMATION, 2013, 2013
[38] Cisplatin-induced nephrotoxicity
Stewart, J. D.
Bolt, H. M.
ARCHIVES OF TOXICOLOGY, 2012, 86 (08) : 1155 - 1156
[39] CISPLATIN-INDUCED NEPHROTOXICITY
MEIJER, S
SLEIJFER, DT
MULDER, NH
DONKER, AJM
NETHERLANDS JOURNAL OF MEDICINE, 1982, 25 (08): : 262 - 269
[40] Cisplatin-induced hyponatremia
Peyrade, F
Taillan, B
Lebrun, C
Bendini, JC
Passerron, C
Dujardin, P
PRESSE MEDICALE, 1997, 26 (32): : 1523 - 1525

← 1 2 3 4 5 →